🇺🇸

US SEC Filing Intelligence

· daily

Federal IT & Cybersecurity Contracts — February 27, 2026

Federal IT & cybersecurity sector shows robust demand with $344M obligated across 3 delivery orders under NAICS 541512, all signaling bullish revenue for contractors ITILITY, BAE Systems, and Valiant Solutions. GSA dominates (78% of value via 2 awards), underscoring agency reliance on IT systems design for ~5-year periods ending 2026+. Upside potential exceeds $540M if options exercised, though low/negative outlays flag near-term cash flow risks warranting monitoring.

3 total filings
· daily

New Federal Contractors — February 27, 2026

This batch of 11 new federal contracts totaling $1.19B signals robust government spending on infrastructure, IT services, and VA support through 2026-2030, with 10 bullish signals dominated by full/open competition awards to established players. High outlay rates in top contracts (e.g., 85% in Granite, 100% in VES) indicate strong execution and cash flow visibility, while unexercised options offer $1B+ upside across portfolio. Neutral signal on JANUS highlights subaward excesses and $0 outlays as outlier risks amid overall bullish backlog growth.

11 total filings
· daily

Significant Contract Modifications ($10M+) — February 27, 2026

This one-day snapshot reveals $1.19B in significant federal contract modifications, with 10/11 bullish signals dominated by infrastructure, IT services, and VA/DOE commitments, signaling robust revenue visibility through 2026-2030+. High outlay rates (e.g., 85-100% in top contracts) underscore execution strength, while unexercised options offer $2B+ collective upside. Neutral signal on JANUS highlights funding delays as outlier risk amid full/open competition wins.

11 total filings
· daily

Contract Deobligations Alert — February 27, 2026

11 contract deobligations total $1.19B in obligations, with 10 bullish signals dominated by construction, IT services, and VA-related awards providing revenue visibility through 2026-2030. High execution rates (e.g., 85% outlayed in Granite's $214M contract) signal strong cash flows, while unexercised options exceed $800M across portfolio for upside. Neutral JANUS ($175M) stands out with $0 outlays and excessive subawards ($335M), flagging funding delays amid broader positive momentum.

11 total filings
· daily

Contract Option Exercises — February 27, 2026

This $1.19B batch of 10 bullish and 1 neutral contract option exercises signals strong federal commitment to infrastructure, IT services, and VA-related programs, providing revenue visibility through 2026-2035 for key contractors. High outlays in top contracts (e.g., 85% in Granite) indicate robust cash flows, while full obligations matching base+options in most cases affirm execution momentum. Investors should prioritize construction and IT/services firms with multi-year tails, monitoring low-outlay contracts for delays amid firm-fixed-price exposures.

11 total filings
· daily

All DOE Contracts — February 27, 2026

L3Harris Technologies benefits from a $75.8M DOE NNSA contract (up to $1.63B with options) awarded to subsidiary BWXT Ordnance Tennessee for high purity depleted uranium production, signaling strong demand in nuclear materials. The 5-year base (potential 10-year extension to 2035) provides long-term revenue visibility but carries firm fixed-price execution risks. Investors should monitor option exercises for revenue upside amid concentrated exposure to this single large award.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — February 27, 2026

Three mega contracts worth $587M signal robust federal spending on infrastructure and IT/professional services, with Granite Construction's $214M DOT award (85% outlayed) providing strongest near-term cash flow visibility through 2026. GSA delivery orders to ITILITY ($199M obligated, $276M potential) and Janus ($175M obligated, $193M potential) offer medium-term upside via options/extensions, but low/zero outlays flag funding delays. Overall bullish tilt (2/3 signals) favors contractors with execution momentum amid long-duration federal commitments.

3 total filings
· daily

High-Value Federal Grants ($5M+) — February 27, 2026

This $1.19B batch of high-value federal contracts signals robust government spending momentum into 2026-2028, with 10/11 bullish awards dominated by infrastructure (18%), IT/services (35%), and VA-related services (20%). High outlay rates in top contracts (e.g., 85% for Granite, 100% for VES) indicate strong near-term cash flows, while unexercised options offer $1B+ upside across the portfolio. Neutral signal on JANUS highlights execution delays as the primary watch item amid firm fixed-price risks in remote/high-complexity projects.

11 total filings
· daily

DOE Energy Grants — February 27, 2026

L3Harris Technologies benefits from a $75.8M DOE NNSA contract (up to $1.63B with options) awarded to subsidiary BWXT Ordnance Tennessee for high purity depleted uranium production, signaling bullish multi-year revenue potential in nuclear defense manufacturing. Firm fixed-price terms and long execution horizon (2025-2030, potential 2035) introduce cost overrun and regulatory risks, with delayed revenue from low initial $7.33M outlay. Investors should monitor option exercises for upside realization amid rising NNSA priorities.

1 total filings
· daily

General Federal Contracts — February 27, 2026

Federal contracts totaling $1.19B signal robust demand in infrastructure, IT services, and VA-related sectors, with 10/11 bullish awards providing revenue visibility through 2026-2030 and $800M+ in potential options upside. High outlay rates (e.g., 85% in Granite, 100% in VES) indicate strong cash flows, though delayed funding in 4 contracts (e.g., $0 outlays in Janus, ConEd) warrants caution. Institutional investors should prioritize construction and defense contractors for near-term execution and long-term backlog growth.

11 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — February 27, 2026

Across 35 SEC filings from the USA S&P 500 Consumer Staples intelligence stream (though spanning diverse sectors like utilities, materials, and consumer discretionary), a cluster of 10+ earnings-related 8-Ks (Items 2.02/7.01) signals active Q4/FY2025 reporting season with neutral sentiment dominating; period-over-period trends reveal mixed performance including HEI's dramatic NI turnaround from -$1.4B to +$123M YoY, UAMY record Q3/9M revenues, PNW 9 consecutive quarters of 4-6.8% sales growth, but sales declines at Callaway (-1.9% H1 2025), Yelp Q4 (-1% YoY), and Elite Express widened losses despite +9.1% FY2025 revenue. Forward-looking highlights include PNW raised sales/EPS guidance to 5-7% CAGR through 2030, Yelp 2026 revenue outlook $1.455-1.475B, and UAMY expansions (smelters to 300tpm, Alaska exploration May 2026). Capital allocation shows UAMY strong $90-92M cash for growth, Wyndham $650M notes to repay debt, but risks emerge from accounting issues (Elauwit non-reliance, MPWR $195M restatement) and unknown material agreements (Ultra Clean, KORE). Portfolio-level patterns: margin resilience in Callaway op income +7.2% H1 despite sales drop, SPAC IPO surge (Clearthink $125M, MOZAYYX upsized $261M), neutral insider activity with no major buys/sells flagged; actionable theme is monitoring restatements and guidance for staples-adjacent consumer names amid broader market rotations.

12 high priority 23 medium 35 total filings
· daily

S&P 500 Industrials Sector SEC Filings — February 27, 2026

Across 56 filings from the USA S&P 500 Industrials stream (broadly encompassing aerospace, machinery, transportation despite some pharma/bank crossovers), dominant themes include a surge in Q4 2025 earnings disclosures (25+ Item 2.02 filings, neutral sentiment, no widespread quant trends disclosed), proactive capital raises/debt refinancings ($200M-$800M tranches in 8 filings for capex/acquisitions), and governance/M&A milestones (board changes, shareholder votes, mergers approved). Period-over-period insights are sparse but highlight revenue growth outliers like IPST (+53-60% QoQ Q4 revenues to $4.6-4.8M, +17-23% FY YoY) offset by massive losses from token markdowns, and Pathfinder Bancorp narrowing FY2025 net loss to $1.9M (-44% YoY improvement). Financing activity signals liquidity bolstering amid neutral sector sentiment (48/56 neutral), with positive outliers in refis (Advanced Drainage $750M revolver, GE HealthCare $500M facility) implying stable balance sheets. No insider trading patterns detected; capital allocation leans toward debt/equity for growth vs dividends/buybacks. Portfolio-level: watch for earnings call catalysts as 20+ filings attach exhibits without disclosed metrics, potential for margin/revenue reveals; industrials show resilience via refis but mixed execution in adjacent sectors.

21 high priority 35 medium 56 total filings
· daily

S&P 500 Financials Sector SEC Filings — February 27, 2026

Across 241 SEC filings from S&P 500 Financials on Feb 27, 2026, overarching themes include mixed earnings with revenue growth in insurers (AXIS GPW +7% YoY to $9.6B) and turnarounds (HEI FY net income $123M from -$1.4B loss, core +20%), but declines in REITs/hotels (Apple Hospitality RevPAR -1.6% YoY FY2025, EBITDA margin -190bps to 34.3%) and occupancy pressures (Saul Centers commercial 94.6% down from 95.2%). Capital allocation robust with AXIS >$1B returns, Apple $58.3M buybacks (4.6M shares), Healthcare Realty $50M repurchases; financings prevalent (Wyndham $650M notes, Tandem $200M convertibles). Delisting risks cluster in small caps (Datavault, reAlpha, Envoy), while M&A catalysts emerge (Carnival DLC unification April 17 vote, FirstSun/First Foundation approvals). Forward guidance positive in pockets (Gogo 2026 rev $905-945M +FCF $90-110M, Healthcare Realty SS NOI 3.5-4.5%). Sentiment mixed (positive 20%, bearish 10%), with portfolio-level trends showing avg revenue +5-10% YoY in winners but -1-5% in laggards, implying selective rotation to insurers/strong balance sheets amid financing/debt trends.

107 high priority 134 medium 241 total filings
· daily

US Material Events SEC 8-K Filings — February 27, 2026

Across 97 8-K filings from February 27, 2026, dominant themes include aggressive capital raising via debt issuances ($200M-$2.5B notes across Tandem, Wyndham, Royal Caribbean, etc.), equity offerings/ATM programs (e.g., $15M Birchtech, $1.75B American Healthcare REIT), and SPAC IPOs ($125M-$261M), signaling robust liquidity pursuits amid neutral-to-positive sentiment in 70% of cases. M&A highlights feature Paramount Skydance's $81B acquisition of Warner Bros. Discovery (7.5x 2026 EBITDA) and Netflix's $2.8B termination fee from the failed WBD deal, reshaping media landscapes. Governance churn is prevalent (25+ officer/director changes, mostly retirements without disagreements), while distressed financings (e.g., 28.6% discount notes for IMAC) and delistings (reAlpha, Avidity) flag microcap risks. No broad period-over-period trends emerge due to event-driven nature, but forward-looking catalysts like Q3 2026 WBD close, annual meetings (e.g., May 2026), and note maturities (18-36 months) dominate. Portfolio implications favor large-cap refinancings reducing costs (e.g., Wyndham, WESCO) over small-cap dilution risks, with media/tech outliers driving alpha.

97 high priority 97 total filings
· daily

S&P 500 Technology Sector SEC Filings — February 27, 2026

Across these 10 S&P 500 Technology stream filings dated Feb 27, 2026, disclosures are predominantly neutral with limited quantitative enriched data, featuring sparse period-over-period trends dominated by Apple Hospitality REIT's (APLE) FY2025 revenue decline of 1.1% YoY and EBITDA margin contraction of 190 bps to 34.3%, alongside Q4 RevPAR drop of 2.6% YoY. Governance events prevail, including a DNOW board member opting not to reelect (no disagreement), Jewett-Cameron AGM with significant shareholder opposition to executive comp (611,957 against votes), and compensatory arrangements at Smurfit Westrock and Iridium Communications. Forward-looking elements include APLE's preliminary Jan 2026 RevPAR down ~1.5% YoY, Intuitive Machines' SEC registration deadline of April 1, 2026, and Iridium's Q1 2026 10-Q for comp plan exhibits. Capital allocation highlights APLE's 4.6M share repurchase for $58.3M and strong balance sheet (35% net debt to cap). Sentiment is neutral in 8/10 filings, mixed in APLE and Jewett due to softening demand offset by buybacks and passed resolutions despite opposition. Portfolio-level implication: low materiality overall (avg 5.2/10), signaling stable but unexciting tech-adjacent operations with watch for dilution risks from registrations and governance pushback.

4 high priority 6 medium 10 total filings
· daily

Nasdaq 100 Stocks SEC Filings — February 27, 2026

The 15 NASDAQ-100 8-K filings dated February 27, 2026, are dominated by earnings-related disclosures (TXNM Energy, NIQ Global Intelligence, Alpha Metallurgical x2) under Items 2.02/7.01 without specific metrics, suggesting quiet period filings ahead of full reports with high materiality (avg 7/10). Netflix's termination of the WBD merger yielded a $2.8B fee, a major cash positive offsetting lost streaming assets amid media M&A volatility. Apple Hospitality REIT disclosed FY2025 results with revenue down 1.1% YoY to $1.4B, RevPAR -1.6% YoY to $117.95, Q4 EBITDA -8.4%, and Jan 2026 RevPAR -1.5%, but countered with $58.3M buybacks and 35% net debt-to-cap. Governance events include Comcast's audit committee addition, Smurfit Westrock officer comp changes, Iridium incentive plans, and Jewett-Cameron's AGM with strong opposition to exec comp (612k against votes). Limited period-over-period data highlights hospitality weakness as the sole quantitative trend, contrasting neutral-to-mixed sentiment portfolio-wide. Amazon's undisclosed material agreement and Intuitive Machines' registration rights add opacity-driven catalysts. Overall, neutral backdrop with actionable cash (Netflix), buybacks (APLE), and exhibit-dependent earnings insights.

6 high priority 9 medium 15 total filings
· daily

Dow Jones 30 Stocks SEC Filings — February 27, 2026

Across 84 SEC filings from February 27, 2026, primarily 8-Ks, a dominant theme is the kickoff of Q4/FY2025 earnings season with 20+ Item 2.02 disclosures (e.g., AXIS Capital, BrightSpring, Delek US), revealing mixed period-over-period trends: revenue growth in insurance (AXIS +7% YoY GPW to $9.6B) contrasted with declines in REITs/hospitality (Apple Hospitality -1.1% YoY revenue, -1.6% RevPAR) and media (Warner Bros Discovery -5% YoY revenue to $37.3B). Capital allocation shines with $1B+ returns at AXIS, Apple Hospitality's 4.6M share buyback ($58.3M), and debt reductions (Fold Holdings extinguished $66.3M notes, Presurance $14M rights proceeds). Forward-looking catalysts cluster around M&A (Carnival DLC unification vote April 17, FirstSun merger approved, Warner Bros Discovery $81B acquisition by PSKY closing Q3 2026) and clinical trials (NeOnc March 4 call). Bearish outliers include delistings (Datavault AI, Envoy Medical, Avidity Biosciences implied), biotech setbacks (Aardvark trial pause, Disc Medicine 20% workforce cut), and distressed financing (IMAC 28.6% discount note). Portfolio-level patterns show resilient financials/insurance vs. pressured consumer-facing (hotels down RevPAR -1.5-2.6% YoY) amid no broad insider selling but neutral board churn; actionable now: favor capital returners, avoid delisting risks.

36 high priority 48 medium 84 total filings
· daily

US SEC Filings Daily Market Digest — February 27, 2026

Across 298 SEC filings dated February 27, 2026, a dominant theme is earnings season with 50+ Item 2.02 disclosures (e.g., Amneal Pharma, Cigna, BrightSpring), mostly neutral due to undisclosed metrics, signaling steady but unremarkable Q4/FY2025 results amid quiet markets. Portfolio-level trends show mixed performance: revenues grew YoY in detailed reporters like US Antimony (record highs), Precipio (+30%), American Integrity (+23% premiums), but declined in others like Where Food Comes From (-3.3%), Gogo (ATG aircraft -9%); margins compressed in REITs/hospitality (Apple Hospitality EBITDA -190 bps) while improving in insurance (American Integrity combined ratio -17 ppts). Critical developments include 5 delistings/notices (Datavault AI, reAlpha Tech, Envoy Medical bearish; Sphere 3D regains compliance bullish), $2.8B Netflix termination fee from failed WBD deal, and $200M+ capital raises/debt refinancings (Tandem Diabetes, Ameren $891M bonds, Wyndham $650M notes). M&A activity surged with 20+ Item 1.01 (e.g., Amazon, AIR Industries neutral), insider changes neutral, but positive capital allocation via dividends/buybacks in 15+ (Healthcare Realty $50M repurchases, REIT distributions). Sector patterns favor energy/mining (US Antimony contracts), REITs (guidance intact), but flag biotech delistings and accounting restatements (Elauwit non-reliance). Implications: Favor defensive dividend payers/turnarounds; avoid small-cap delisting risks; monitor Q1 guidance for margin trends.

115 high priority 183 medium 298 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — February 27, 2026

Across 50 filings in the S&P 500 Consumer Discretionary intelligence stream (with broader SEC captures), neutral sentiment dominates (70%+ filings) amid frequent board/officer changes and undisclosed Reg FD items, but mixed earnings reveal revenue declines averaging -4% YoY where reported (e.g., Where Food -3.3% FY2025, Topgolf Callaway -1.9% H1 2025) offset by margin gains (Topgolf +150 bps Q1 gross margin) and operating income growth (Topgolf +7.2% H1). Key CD highlights include Amazon's undisclosed material agreement (materiality 8/10), Netflix's $2.8B termination fee from failed WBD acquisition (materiality 10/10), and Avis Budget's resolving shareholder suits. Portfolio trends show positive capital allocation via buybacks ($858M FTI, 183k shares Where Food), debt cleanups (Fold $66.3M extinguished), and issuances ($600M HA, $200M PennantPark), signaling financial flexibility despite no insider trading patterns disclosed. M&A resolutions (First Foundation/FirstSun approvals, Netflix termination) build a catalyst calendar into Q2 2026, implying sector resilience in entertainment/retail but caution on growth amid losses (Sable $410M FY2025). Actionable: Favor debt deleveraging plays; monitor merger closes and dividend records for near-term pops.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — February 27, 2026

Across 23 filings from the USA S&P 500 Healthcare stream (with some adjacent financials/REITs), dominant themes include neutral board departures (5/23 filings, e.g., Lifeward, Pulse Biosciences, Western New England), Nasdaq compliance threats in biotechs (4/23, Jupiter Neurosciences, Ensysce Biosciences, CIMG, Avidity Biosciences), and limited financial disclosures showing one standout positive (Precipio's 30% YoY revenue growth to $24M, EBITDA inflection to +$1.23M). Period-over-period trends are sparse but highlight Precipio's outperformance with 23% Q4 revenue growth and positive adjusted EBITDA ($0.95M vs $0.40M prior), contrasting Disc Medicine's negative restructuring (20% workforce cut, $2M Q1 charges post-FDA setback). Capital allocation features steady dividends (Triumph Financial $0.44525/depositary share payable Mar 30) and ATM equity raises (Bridgewater $50M, FrontView $75M), signaling liquidity needs amid compliance risks. Portfolio-level patterns reveal biotech vulnerability to delisting (materiality 9/10 average), mixed AGM support (Jewett-Cameron), and high-risk M&A/change-of-control (Avidity). Most critical: Biotech delisting cascades could pressure sector liquidity; actionable now via short-term trades on compliance deadlines (Aug 2026) and Precipio's April catalyst.

11 high priority 12 medium 23 total filings